Royal London Hospital for Integrated Medicine, UCLH NHS Foundation Trust, London, UK.
Royal London Hospital for Integrated Medicine, UCLH NHS Foundation Trust and University of West London, UK.
Clin Exp Rheumatol. 2022 Jun;40(6):1189-1193. doi: 10.55563/clinexprheumatol/m1ijpc. Epub 2022 Jun 23.
To evaluate the Royal London Hospital for Integrated Medicine (RLHIM) multicomponent fibromyalgia service.
Mixed methods approach consisting of the completion of validated quantitative outcome measures (Patient Health Questionnaire-9; Generalised Anxiety Disorder-7; Pain Catastrophising Scale; Patient Self-Efficacy Questionnaire) pre- and post-treatment to explore the impact of treatment; and qualitative focus groups with patients at their follow-up appointments to explore patients' experiences and perspectives on the service.
138 fibromyalgia patients attended the RLHIM group fibromyalgia service during the period of the evaluation. Baseline scores demonstrate that patients were significantly impaired pre-treatment according to all outcome measures. At the end of the course of treatment, scores for all outcome measures showed clinically and statistically significant improvements. These improvements were maintained at both 6- and 9-month follow-up appointments. Qualitative analysis indicated that those participating valued the multicomponent treatment approach, and perceived the service as having a positive impact on their fibromyalgia and overall quality of life, enabling patients to effectively manage their condition.
Patients attending the RLHIM multicomponent fibromyalgia service appear to have demonstrable improvements in presenting symptoms, and quality of life. The findings support a multicomponent approach to the treatment of fibromyalgia.
评估伦敦皇家综合医学医院(RLHIM)多组分纤维肌痛服务。
采用混合方法,包括在治疗前后完成经过验证的定量结果测量(患者健康问卷-9;广泛性焦虑症-7;疼痛灾难化量表;患者自我效能问卷),以探讨治疗的影响;并在患者随访预约时进行患者焦点小组,以探讨患者对服务的体验和看法。
在评估期间,共有 138 名纤维肌痛患者参加了 RLHIM 组纤维肌痛服务。基线评分表明,根据所有结果测量,患者在治疗前明显受损。在治疗过程结束时,所有结果测量的评分均显示出临床和统计学上的显著改善。这些改善在 6 个月和 9 个月的随访预约中均得到维持。定性分析表明,那些参与者重视多组分治疗方法,并认为该服务对他们的纤维肌痛和整体生活质量产生了积极影响,使患者能够有效地管理他们的病情。
参加 RLHIM 多组分纤维肌痛服务的患者的症状和生活质量似乎有明显改善。研究结果支持纤维肌痛的多组分治疗方法。